SCHEMBL6414970

SCHEMBL6414970

O=C1CCC(c2ccccc2Cl)O1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.43
TP53 P04637 1/20 0.43
RECQL P46063 1/20 0.43
HTR6 P50406 6/20 0.40
GAA P10253 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CDK4 P11802 4/20 0.39
CCND1 P24385 4/20 0.39
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
SLC6A3 Q01959 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30758308 0.79 ALDH1A1 (0.41) HTR6GAACDK4CCND1HTR2C
SCHEMBL576000 0.76 SLC6A4 (0.48) TP53SMN1; SMN2ALDH1A1KDM4ESLC6A3
SCHEMBL15819998 0.76 HSD17B10 (0.46) GAASMN1; SMN2ALDH1A1KDM4ESLC6A3
SCHEMBL10569317 0.75 CYP19A1 (0.48) RECQLHTR6HTR2AHTR2CHTR2B
SCHEMBL11760427 0.74 GUSB (0.44) LDHAKDM4E
SCHEMBL9012682 0.73 TSHR (0.46) SMN1; SMN2ALDH1A1KDM4E
SCHEMBL982856 0.73 TSHR (0.46) SMN1; SMN2ALDH1A1KDM4E
SCHEMBL7339250 0.73 TSHR (0.46) SMN1; SMN2ALDH1A1KDM4E
SCHEMBL14580259 0.72 PLA2G6 (0.43) TP53RECQLGAASMN1; SMN2HTR2A
SCHEMBL11634647 0.72 ALDH1A1 (0.44) GAASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050019668-A1 Ionic conduction structural member, secondary battery and method of producing same CANON KABUSHIKI KAISHA (JP) 2005-01-27 US disclosed
US-4839360-A ANTIDEPRESSANTS; NERVOUS AND PSYCHOLOGICAL DISORDERS; COGNITION ACTIVATORS TANABE SEIYAKU CO., LTD. (JP) 1989-06-13 US disclosed
EP-0270093-A2 Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties TANABE SEIYAKU CO., LTD. (JP) 1988-06-08 EP disclosed